Ribozyme and omics

Anti-cancer development based on RNA Platform technology Core competence to meet diverse unmet medical needs

Introduction

Ribozyme and omics

Rznomics Inc. is a biotech company founded by Professor Seong-Wook Lee at Dankook University in August 2017.
We are working on the development of gene therapies for cancer and intractable diseases.

CEO
Lee, Seong-Wook
Established date
August 29, 2017
Business Area
Development of gene therapies for cancer/intractable diseases * Technology transfer from Dankook University (Oct. 11, 2017)
Head Office
#327, Software & ICT Hall, 152, Jukjeon-ro, Suji-gu, Yongin, 16890, Korea

Vision

Treatment/conquest of human intractable diseases through development of
innovative RNA-based biopharmaceutical

Objective and Unit

Platform

RNA Replacement Enzyme
(Trans-splicing ribozyme)